These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 25929666)
21. A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings: Case report and literature review. Conforti R; Capasso R; Galasso R; Cirillo M; Taglialatela G; Galasso L Medicine (Baltimore); 2016 Sep; 95(36):e4585. PubMed ID: 27603348 [TBL] [Abstract][Full Text] [Related]
22. Tumour-like lesions in multiple sclerosis. Jamroz-Wiśniewska A; Janczarek M; Belniak E; Stelmasiak Z; Bartosik-Psujek H Neurol Neurochir Pol; 2008; 42(2):161-7. PubMed ID: 18512174 [TBL] [Abstract][Full Text] [Related]
23. [The clinical features, neuroimaging findings and pathological characteristics of 26 patients with pathologically proven tumor-like inflammatory demyelinating diseases]. Qi XK; Liu JG; Qian HR; Qiu F; Yao S; Li CQ; Wang YM Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):750-3. PubMed ID: 21092444 [TBL] [Abstract][Full Text] [Related]
24. [Analysis of pathological characteristics of acute and chronic cerebral tumefactive demyelinating lesions]. Sun C; Liu J; Gui Q; Lu D; Qi X Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(45):3557-61. PubMed ID: 25622833 [TBL] [Abstract][Full Text] [Related]
27. [Diagnosis of pediatric multiple sclerosis initially presenting with tumefactive demyelinating lesion using ¹H-magnetic resonance spectroscopy]. Kageyama T; Gotoh Y; Sano F; Katoh T; Nambu M; Okada T; Suenaga T Rinsho Shinkeigaku; 2011 Sep; 51(9):688-93. PubMed ID: 21946426 [TBL] [Abstract][Full Text] [Related]
28. Pseudotumoral demyelination: a diagnosis pitfall (report of three cases). Heyman D; Delhaye M; Fournier D; Mercier P; Rousselet MC; Menei P J Neurooncol; 2001 Aug; 54(1):71-6. PubMed ID: 11763425 [TBL] [Abstract][Full Text] [Related]
29. A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion. Miyaue N; Yamanishi Y; Tada S; Ando R; Yabe H; Nagai M; Nomoto M Mult Scler Relat Disord; 2019 Jun; 31():62-64. PubMed ID: 30933712 [TBL] [Abstract][Full Text] [Related]
30. Tumefactive demyelinating lesion: experience with two unusual patients. Sinha MK; Garg RK; Bhatt ML; Chandra A J Postgrad Med; 2010; 56(2):146-9. PubMed ID: 20622396 [TBL] [Abstract][Full Text] [Related]
33. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. Karussis D J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923 [TBL] [Abstract][Full Text] [Related]
34. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology. Kobayashi M; Shimizu Y; Shibata N; Uchiyama S J Neurol; 2014 Oct; 261(10):1902-10. PubMed ID: 25034274 [TBL] [Abstract][Full Text] [Related]
36. Tumefactive multiple sclerosis versus high grade glioma: A diagnostic dilemma. French H; Fontes-Villalba A; Maharaj M; Naidoo CSY; Bhatia K; Paterson A; Cook R; Parratt J Surg Neurol Int; 2022; 13():146. PubMed ID: 35509579 [TBL] [Abstract][Full Text] [Related]
37. Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations. Jeong IH; Kim SH; Hyun JW; Joung A; Cho HJ; Kim HJ J Neurol Sci; 2015 Nov; 358(1-2):118-24. PubMed ID: 26333950 [TBL] [Abstract][Full Text] [Related]
38. [Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature]. Sierra-Marcos A; Mitjana R; Castilló J; Edo MC; Horga-Hernández A; Tintoré M; Río-Izquierdo J; Auger-Acosta C; Rovira A; Montalban X Rev Neurol; 2010 Aug; 51(3):129-34. PubMed ID: 20645263 [TBL] [Abstract][Full Text] [Related]